Prof Roden, Germany explains why PPAR’s are interesting therapeutic targets not only to improve adipose tissue function but also for the liver. The approach can go beyond the improvement of liver function and aim at a more systemic approach with cardiovascular benefits.

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In